Literature DB >> 2831024

Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells.

T L Clemens1, K P Garrett, X Y Zhou, J W Pike, M R Haussler, D W Dempster.   

Abstract

We have used a monoclonal antibody (9A7) against the purified avian 1,25-dihydroxyvitamin D3 receptor to develop an immunocytochemical technique for visualization of the protein in fixed tissues and cultured cells. In Bouin's-fixed, chick intestine, 1,25-dihydroxyvitamin D3 receptor-like immunoreactivity was localized mainly in nuclei of epithelial cells and was more abundant in the crypt than in the villar cells. Receptor staining was low or undetectable in liver hepatocytes but was present in nuclei of cells lining the hepatic sinusoids. In rat brain, receptor-like immunoreactivity was abundant and widely distributed, but did not always coincide with the presence of vitamin D-dependent calcium-binding protein; 1,25-dihydroxyvitamin D3 receptor was absent from cerebellar Purkinje cells that contained abundant calcium-binding protein. In disaggregated rat bone cells, receptor immunoreactivity was present in mononuclear cells including osteoblasts and fibroblasts but was absent from osteoclasts. Two separate clones of osteoblast-like, rat osteosarcoma cells, shown in previous studies to be either receptor positive (17/2.8) or negative (24.1), demonstrated nuclear immunoreactivity in exact concordance with receptor levels as determined by ligand binding. The phenomenon of hormone-induced up-regulation of receptor was visualized in receptor-positive 3T6 fibroblasts by demonstration of markedly enhanced nuclear reactivity in cells treated with 10(-7) M 1,25-dihydroxyvitamin D3 for 48 h. Our studies demonstrate the feasibility of the immunocytochemical approach to visualize the 1,25-dihydroxyvitamin D3 receptor in target tissues and show that it is predominantly a nuclear protein in the relatively unoccupied and fully activated states. Moreover, the vitamin D-dependent calcium binding is not a universal marker for 1,25-dihydroxyvitamin D3 action. Rather, our observations suggest that the expression of the 1,25-dihydroxyvitamin D3 receptor may be connected with the state of cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831024     DOI: 10.1210/endo-122-4-1224

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

1.  Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice.

Authors:  H Sato; I Sugimoto; T Matsunaga; M Tsuchimoto; T Ohta; H Uno; M Kiyoki
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

Review 2.  Vitamin D sites and mechanisms of action: a histochemical perspective. Reflections on the utility of autoradiography and cytopharmacology for drug targeting.

Authors:  W E Stumpf
Journal:  Histochem Cell Biol       Date:  1995-12       Impact factor: 4.304

3.  Calbindin-D9K immunolocalization and vitamin D-dependence in the bone of growing and adult rats.

Authors:  N Balmain; A Berdal; D Hotton; P Cuisinier-Gleizes; H Mathieu
Journal:  Histochemistry       Date:  1989

4.  Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture.

Authors:  Edson Mantovani Barbosa; Sueli Nonogaki; Maria Lucia Hirata Katayama; Maria Aparecida Azevedo Koike Folgueira; Venâncio Ferreira Avancini Alves; Maria Mitzi Brentani
Journal:  Virchows Arch       Date:  2003-12-02       Impact factor: 4.064

Review 5.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

6.  Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide.

Authors:  Mahdi Goudarzvand; Mohammad Javan; Javad Mirnajafi-Zadeh; Sabah Mozafari; Taki Tiraihi
Journal:  Cell Mol Neurobiol       Date:  2009-09-19       Impact factor: 5.046

7.  Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells.

Authors:  J P van Leeuwen; H A Pols; J P Schilte; T J Visser; J C Birkenhäger
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

Review 8.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

Review 9.  Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

Authors:  Jennifer S Buell; Bess Dawson-Hughes
Journal:  Mol Aspects Med       Date:  2008-05-13

Review 10.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.